These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24981880)

  • 21. Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance.
    Giannella A; Radu CM; Franco L; Campello E; Simioni P; Avogaro A; de Kreutzenberg SV; Ceolotto G
    Cardiovasc Diabetol; 2017 Sep; 16(1):118. PubMed ID: 28927403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can miR-145-5p be used as a marker in diabetic patients?
    Shahrokhi SZ; Saeidi L; Sadatamini M; Jafarzadeh M; Rahimipour A; Kazerouni F
    Arch Physiol Biochem; 2022 Oct; 128(5):1175-1180. PubMed ID: 32412315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum microRNA-33 levels in pre-diabetic and diabetic patients.
    Shahouzehi B; Eghbalian M; Fallah H; Aminizadeh S; Masoumi-Ardakani Y
    Mol Biol Rep; 2021 May; 48(5):4121-4128. PubMed ID: 34146198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.
    Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH
    Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Serum miR-146a and miR-155 as Novel Noninvasive Complementary Biomarkers for Ankylosing Spondylitis.
    Qian BP; Ji ML; Qiu Y; Wang B; Yu Y; Shi W; Luo YF
    Spine (Phila Pa 1976); 2016 May; 41(9):735-42. PubMed ID: 27128253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.
    Avgeris M; Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Scorilas A; Fragoulis EG; Christodoulou MI
    Diabetes Res Clin Pract; 2020 Jun; 164():108187. PubMed ID: 32360711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.
    Karolina DS; Armugam A; Tavintharan S; Wong MT; Lim SC; Sum CF; Jeyaseelan K
    PLoS One; 2011; 6(8):e22839. PubMed ID: 21829658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro.
    Heilmeier U; Hackl M; Skalicky S; Weilner S; Schroeder F; Vierlinger K; Patsch JM; Baum T; Oberbauer E; Lobach I; Burghardt AJ; Schwartz AV; Grillari J; Link TM
    J Bone Miner Res; 2016 Dec; 31(12):2173-2192. PubMed ID: 27345526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.
    Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Sideris DC; Fragoulis EG; Christodoulou MI
    Endocrine; 2019 Nov; 66(2):226-239. PubMed ID: 31559537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
    Cui X; You L; Zhu L; Wang X; Zhou Y; Li Y; Wen J; Xia Y; Wang X; Ji C; Guo X
    Metabolism; 2018 Jan; 78():95-105. PubMed ID: 28966078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and clinical significance of miR-1 and miR-133 in pre-diabetes.
    Al-Kafaji G; Al-Muhtaresh HA; Salem AH
    Biomed Rep; 2021 Mar; 14(3):33. PubMed ID: 33585035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus.
    Zhao Z; Li X; Jian D; Hao P; Rao L; Li M
    Acta Diabetol; 2017 Mar; 54(3):237-245. PubMed ID: 27878383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can circulating miR-7-1-5p, and miR-33a-5p be used as markers of T2D patients?
    Saeidi L; Shahrokhi SZ; Sadatamini M; Jafarzadeh M; Kazerouni F
    Arch Physiol Biochem; 2023 Jun; 129(3):771-777. PubMed ID: 33476198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of Circulating Cardiomyocyte-Enriched miR-1 and miR-133 Associate with the Risk of Coronary Artery Disease in Type 2 Diabetes Patients and Serve as Potential Biomarkers.
    Al-Muhtaresh HA; Salem AH; Al-Kafaji G
    J Cardiovasc Transl Res; 2019 Aug; 12(4):347-357. PubMed ID: 30610670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.
    Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T
    J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of hsa-miR-152-3p are associated with diabetic nephropathy in patients with type 2 diabetes.
    Roux M; Perret C; Feigerlova E; Mohand Oumoussa B; Saulnier PJ; Proust C; Trégouët DA; Hadjadj S
    Nephrol Dial Transplant; 2018 Dec; 33(12):2201-2207. PubMed ID: 29361146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
    Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
    IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Pilot Study: The Effect of Roux-en-Y Gastric Bypass on the Serum MicroRNAs of the Type 2 Diabetes Patient.
    Lirun K; Sewe M; Yong W
    Obes Surg; 2015 Dec; 25(12):2386-92. PubMed ID: 26138690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2.
    Wang X; Sundquist J; Zöller B; Memon AA; Palmér K; Sundquist K; Bennet L
    PLoS One; 2014; 9(1):e86792. PubMed ID: 24497980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.